Subscribe
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
TESTIMONY
Remarks to the European Parliament on EFSD/ EFSD+
September 24, 2025
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CGD NOTE
February 07, 2025
The political economy of global health financing is increasingly driven by fiscal constraints, geopolitical instability, and shifting power dynamics. The COVID-19 pandemic stalled or reversed health gains, and countries and donors now face tightening budgets and rising debt repayments, threatening t...
WORKING PAPER
January 29, 2025
This study estimates the costs of four key interventions to mitigate antimicrobial resistance globally by 2050. These interventions include improving access to water, sanitation, and hygiene, enhancing childhood vaccination, developing new antibiotics, and increasing access to healthcare and existin...
WORKING PAPER
January 29, 2025
This study estimates the global inpatient healthcare costs attributable to antimicrobial resistance (AMR) and projects future expenditures across different scenarios. It finds that AMR accounts for 25.4 million hospital admissions annually, resulting in $66.4 billion in excess healthcare costs, with...
WORKING PAPER
January 29, 2025
Antimicrobial resistance (AMR) poses a major global challenge, affecting both human health and economies. This research models the potential impacts of AMR on global GDP and various sectors, showing that while better treatment and combined interventions can boost economic growth, accelerated resista...